speb/financial-data huggingface dataset:
DuPont ROE decomposition for GVCT.L (quarterly period ending 2026-03-31)
Equity multiplier (leverage): 1.0144353957658476
ROE archetype: Standard Business
DuPont ROE decomposition for GVF.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.1389486158394961
ROE archetype: Standard Business
DuPont ROE decomposition for GVH (annual period ending 2022-09-30)
ROE: 90.11102794549922%
Net margin: 3.372966941362953%
Asset turnover: 9.530299447571679
Equity multiplier (leverage): 2.8032337459113847
EBIT margin: 3.401770669537021%
Interest burden factor: 1.146414471832451
Tax burden factor: 0.8648989952902898
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for GVH (annual period ending 2023-09-30)
ROE: 152.49751044813988%
Net margin: 5.796628611863388%
Asset turnover: 5.289264499377842
Equity multiplier (leverage): 4.97384208150267
EBIT margin: 6.1703885739176245%
Interest burden factor: 1.1070591815398727
Tax burden factor: 0.8485786949559837
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for GVH (annual period ending 2024-09-30)
ROE: 47.513789684811606%
Net margin: 8.095486753801154%
Asset turnover: 2.730650016855198
Equity multiplier (leverage): 2.1493674301081933
EBIT margin: 8.101804702355398%
Interest burden factor: 1.1662359623089533
Tax burden factor: 0.8567907459473849
ROE archetype: Balanced Compounder
DuPont ROE decomposition for GVH (annual period ending 2025-09-30)
ROE: 8.837899850968208%
Net margin: 2.8984181222194554%
Asset turnover: 2.4102503564037474
Equity multiplier (leverage): 1.265102994575886
EBIT margin: 4.065543830350735%
Interest burden factor: 0.9218457562241454
Tax burden factor: 0.7733643140145685
ROE archetype: Standard Business
DuPont ROE decomposition for GVPTECH.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.0353584480790996
ROE archetype: Standard Business
DuPont ROE decomposition for GVPTECH.NS (quarterly period ending 2024-12-31)
Net margin: -270.14218009478674%
EBIT margin: -273.02527646129545%
ROE archetype: Standard Business
DuPont ROE decomposition for GVPTECH.NS (quarterly period ending 2025-03-31)
ROE: -1.2787967852528517%
Net margin: -206.55657611881963%
Asset turnover: 0.004747212378815042
Equity multiplier (leverage): 1.3041388969674477
EBIT margin: -196.85362517099864%
ROE archetype: Low Return
DuPont ROE decomposition for GVPTECH.NS (quarterly period ending 2025-06-30)
Net margin: 51.24688887804402%
EBIT margin: 51.283490312820255%
Interest burden factor: 1.0033782176333446
Tax burden factor: 0.995921851289833
ROE archetype: Standard Business
DuPont ROE decomposition for GVPTECH.NS (quarterly period ending 2025-09-30)
ROE: -105.90875821654615%
Net margin: -4962.478702940368%
Asset turnover: 0.015154291425477867
Equity multiplier (leverage): 1.4083078020240503
EBIT margin: -4968.606760098927%
ROE archetype: Low Return
DuPont ROE decomposition for GVPTECH.NS (quarterly period ending 2025-12-31)
Net margin: -957.5713240673007%
EBIT margin: -1231.1631309436723%
ROE archetype: Standard Business
DuPont ROE decomposition for GVPTECH.NS (quarterly period ending 2026-03-31)
ROE: -2.460956274678007%
Net margin: -472.215736633201%
Asset turnover: 0.003542110843341609
Equity multiplier (leverage): 1.471300200161833
EBIT margin: -442.86714919448985%
ROE archetype: Low Return
DuPont ROE decomposition for H2G.AX (annual period ending 2022-12-31)
ROE: -52.85143153630384%
Net margin: -858.1757580517923%
Asset turnover: 0.05589882953837837
Equity multiplier (leverage): 1.101736654358188
EBIT margin: -1015.977228564696%
ROE archetype: Low Return
DuPont ROE decomposition for H2G.AX (annual period ending 2023-12-31)
ROE: -48.76684112622567%
Net margin: -1389.3604696897103%
Asset turnover: 0.031061438633017642
Equity multiplier (leverage): 1.1300251789701135
EBIT margin: -1299.7075166086229%
ROE archetype: Low Return
DuPont ROE decomposition for H2G.AX (annual period ending 2024-12-31)
ROE: -35.896965807580735%
Net margin: -2683.0913055581327%
Asset turnover: 0.011176803554831185
Equity multiplier (leverage): 1.1970289989155491
EBIT margin: -2492.465435649995%
ROE archetype: Low Return
DuPont ROE decomposition for H2G.AX (annual period ending 2025-12-31)
ROE: -35.663149750140626%
Net margin: -450.3984653076319%
Asset turnover: 0.06510376717891113
Equity multiplier (leverage): 1.216232699850952
EBIT margin: -965.9173484953543%
ROE archetype: Low Return
DuPont ROE decomposition for HABA.DE (quarterly period ending 2024-12-31)
ROE: 1.1469819975387068%
Net margin: 17.986956024257218%
Asset turnover: 0.023131540732297343
Equity multiplier (leverage): 2.756730858096243
EBIT margin: 13.623707998016704%
Interest burden factor: 1.32026875699888
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for HABA.DE (quarterly period ending 2025-03-31)
ROE: 0.6211533155048495%
Net margin: 9.75619240191313%
Asset turnover: 0.023309977708139976
Equity multiplier (leverage): 2.731345208100699
EBIT margin: 23.004238441497844%
Interest burden factor: 0.424104124408384
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for HABA.DE (quarterly period ending 2025-06-30)
ROE: 1.0534712914163376%
Net margin: 15.738850502512564%
Asset turnover: 0.02443854837739905
Equity multiplier (leverage): 2.738888099765755
EBIT margin: 18.086526381909547%
Interest burden factor: 0.8701975255046669
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for HABA.DE (quarterly period ending 2025-12-31)
ROE: 0.8579339390866905%
Net margin: 12.71431323444423%
Asset turnover: 0.024428764105011217
Equity multiplier (leverage): 2.762227508481847
EBIT margin: 25.902523598535925%
Interest burden factor: 0.4908522980812138
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for HABA.DE (quarterly period ending 2026-03-31)
ROE: 0.7112249247695084%
Net margin: 10.80345337170413%
Asset turnover: 0.02390856326844124
Equity multiplier (leverage): 2.7535368139017926
EBIT margin: 23.846931632573693%
Interest burden factor: 0.4530332681017613
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for HAL (annual period ending 2022-12-31)
ROE: 19.99498558355271%
Net margin: 7.8583041828841695%
Asset turnover: 0.8728015480541819
Equity multiplier (leverage): 2.9152563620408674
EBIT margin: 15.140168497807558%
Interest burden factor: 0.686625447445493
Tax burden factor: 0.7559241706161137
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for HAL (annual period ending 2023-12-31)
ROE: 30.580126364158527%
Net margin: 11.564862281692587%
Asset turnover: 0.9603237515123701
Equity multiplier (leverage): 2.7534750143595637
EBIT margin: 17.738291771656964%
Interest burden factor: 0.8236590742101396
Tax burden factor: 0.7915551590841511
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for HAL (annual period ending 2024-12-31)
ROE: 25.18392472849207%
Net margin: 10.965829846582984%
Asset turnover: 0.9128307141436244
Equity multiplier (leverage): 2.5158900955908114
EBIT margin: 17.163528591352858%
Interest burden factor: 0.8212290502793296
Tax burden factor: 0.7779839208410637
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for HAL (annual period ending 2025-12-31)
ROE: 12.273785208758847%
Net margin: 5.82401730977281%
Asset turnover: 0.8768899341858213
Equity multiplier (leverage): 2.4033154419797653
EBIT margin: 13.933465560764516%
Interest burden factor: 0.5729537366548043
Tax burden factor: 0.7295313382269905
ROE archetype: Standard Business
DuPont ROE decomposition for HAL.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 2.7731494389908566
ROE archetype: Standard Business
DuPont ROE decomposition for HAL.NS (quarterly period ending 2025-03-31)
ROE: 11.894381976473765%
Net margin: 29.027033142698645%
Asset turnover: 0.14074391982596293
Equity multiplier (leverage): 2.911451703582748
EBIT margin: 33.34547458548816%
Interest burden factor: 1.1423686814293343
Tax burden factor: 0.7620078717525189
ROE archetype: Standard Business
DuPont ROE decomposition for HAL.NS (quarterly period ending 2025-06-30)
Net margin: 28.714819018844118%
EBIT margin: 22.81568205917813%
Interest burden factor: 1.686518294845792
Tax burden factor: 0.7462452340762871
ROE archetype: Standard Business
DuPont ROE decomposition for HAL.NS (quarterly period ending 2025-09-30)
ROE: 4.4966823204278485%
Net margin: 25.179788824504683%
Asset turnover: 0.05382770029727567
Equity multiplier (leverage): 3.317678494501696
EBIT margin: 20.128201840204806%
Interest burden factor: 1.6691250318538173
Tax burden factor: 0.7494768700212844
ROE archetype: Low Return
DuPont ROE decomposition for HAL.NS (quarterly period ending 2025-12-31)
Net margin: 24.246376058606533%
EBIT margin: 20.322777575726086%
Interest burden factor: 1.5894120579569349
Tax burden factor: 0.7506323362058218
ROE archetype: Standard Business
DuPont ROE decomposition for HAL.NS (quarterly period ending 2026-03-31)
ROE: 10.22322059418291%
Net margin: 30.095822813862743%
Asset turnover: 0.10529353298605539
Equity multiplier (leverage): 3.2261147629651643
EBIT margin: 31.766553821436766%
Interest burden factor: 1.2607371382382557
Tax burden factor: 0.751469869247452
ROE archetype: Standard Business
DuPont ROE decomposition for HAVA (quarterly period ending 2025-03-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for HAVA (quarterly period ending 2025-06-30)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for HAVA (quarterly period ending 2025-09-30)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for HAVA (quarterly period ending 2025-12-31)
ROE: 1.1621014861883865%
Asset turnover: 0
Equity multiplier (leverage): 1.0515077357243379
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for HAVA (quarterly period ending 2026-03-31)
ROE: 0.773711497642876%
Asset turnover: 0
Equity multiplier (leverage): 1.0339288473725254
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for HBAN (quarterly period ending 2025-03-31)
ROE: 2.5920140583813334%
Net margin: 27.65625%
Asset turnover: 0.00916048016183515
Equity multiplier (leverage): 10.231182270819096
Tax burden factor: 0.8131699846860643
ROE archetype: Low Return
DuPont ROE decomposition for HBAN (quarterly period ending 2025-06-30)
ROE: 2.614820532612891%
Net margin: 27.966976264189885%
Asset turnover: 0.009287436082983097
Equity multiplier (leverage): 10.067010806638363
Tax burden factor: 0.8495297805642633
ROE archetype: Low Return
DuPont ROE decomposition for HBAN (quarterly period ending 2025-09-30)
ROE: 2.926761605326429%
Net margin: 29.662605435801314%
Asset turnover: 0.010211259181280952
Equity multiplier (leverage): 9.662705751803218
Tax burden factor: 0.8263707571801566
ROE archetype: Low Return
DuPont ROE decomposition for HBAN (quarterly period ending 2025-12-31)
ROE: 2.2415086253080467%
Net margin: 24.45067788686302%
Asset turnover: 0.009826937477890539
Equity multiplier (leverage): 9.328918889960356
Tax burden factor: 0.8288431061806656
ROE archetype: Low Return
DuPont ROE decomposition for HBAN (quarterly period ending 2026-03-31)
ROE: 1.8504213483146066%
Net margin: 20.481927710843372%
Asset turnover: 0.010080747848095314
Equity multiplier (leverage): 8.962043539325842
Tax burden factor: 0.8221528861154446
ROE archetype: Low Return
DuPont ROE decomposition for HBC.OL (quarterly period ending 2024-12-31)
ROE: -73.65051553339177%
Net margin: -67.28229753439838%
Asset turnover: 0.1914254232194731
Equity multiplier (leverage): 5.718410944133704
EBIT margin: -56.44103795364299%
ROE archetype: Low Return
DuPont ROE decomposition for HBC.OL (quarterly period ending 2025-03-31)
ROE: -81.61832736562424%
Net margin: -54.40908269391913%
Asset turnover: 0.17478597872057405
Equity multiplier (leverage): 8.582418651217221
EBIT margin: -48.45636922268045%
ROE archetype: Low Return
DuPont ROE decomposition for HBC.OL (quarterly period ending 2025-06-30)
ROE: -197.15528145815114%
Net margin: -36.790812524656275%
Asset turnover: 0.1813679444778307
Equity multiplier (leverage): 29.546667524860496
EBIT margin: -21.70628716704899%
ROE archetype: Low Return
DuPont ROE decomposition for HBC.OL (quarterly period ending 2025-09-30)
Net margin: -51.579637794701746%
Asset turnover: 0.14162332393607804
EBIT margin: -55.757388040666115%
ROE archetype: Standard Business
DuPont ROE decomposition for HBC.OL (quarterly period ending 2025-12-31)
Net margin: -66.90921690921691%
Asset turnover: 0.18303706386726148
EBIT margin: -51.82813582813582%
ROE archetype: Standard Business
DuPont ROE decomposition for HBC.OL (quarterly period ending 2026-03-31)
Net margin: -73.90856172689789%
Asset turnover: 0.13175224359454704
EBIT margin: -67.93192659067022%
ROE archetype: Standard Business
DuPont ROE decomposition for HBLENGINE.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.3421962796171032
ROE archetype: Standard Business
DuPont ROE decomposition for HBLENGINE.NS (quarterly period ending 2025-03-31)
ROE: 3.032401496704329%
Net margin: 9.451616972959332%
Asset turnover: 0.2402531716166829
Equity multiplier (leverage): 1.3354002685648578
EBIT margin: 14.420286807687454%
Interest burden factor: 1.0298920968212306
Tax burden factor: 0.6364151210533767
ROE archetype: Low Return
DuPont ROE decomposition for HBLENGINE.NS (quarterly period ending 2025-06-30)
Net margin: 23.821332610577418%
EBIT margin: 29.966713234791925%
Interest burden factor: 1.0564689689897848
Tax burden factor: 0.7524370912373893
ROE archetype: Standard Business
DuPont ROE decomposition for HBLENGINE.NS (quarterly period ending 2025-09-30)
ROE: 19.51287102771718%
Net margin: 31.668165835309516%
Asset turnover: 0.456812213535149
Equity multiplier (leverage): 1.3488403730557417
EBIT margin: 43.49415324229292%
Interest burden factor: 0.9783225854970014
Tax burden factor: 0.7442347605503882
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for HBLENGINE.NS (quarterly period ending 2025-12-31)
Net margin: 25.239119491098805%
EBIT margin: 33.191844766829895%
Interest burden factor: 1.024059839371273
Tax burden factor: 0.7425359318724966
ROE archetype: Standard Business
DuPont ROE decomposition for HBLENGINE.NS (quarterly period ending 2026-03-31)
ROE: 2.880080235647035%
Net margin: 10.552539230616434%
Asset turnover: 0.20536633952822717
Equity multiplier (leverage): 1.3289797061640494
EBIT margin: 9.936767529629874%
Interest burden factor: 1.1236048642345493
Tax burden factor: 0.9451445515196442
ROE archetype: Low Return
DuPont ROE decomposition for HBMN.SW (annual period ending 2023-03-31)
ROE: -8.254018755697563%
Asset turnover: -0.07530845140477338
Equity multiplier (leverage): 1.085383891581598
ROE archetype: Low Return
DuPont ROE decomposition for HBMN.SW (annual period ending 2024-03-31)
ROE: -0.06265416018350149%
Net margin: -78.535170413343%
Asset turnover: 0.0007435021150697456
Equity multiplier (leverage): 1.0730093696905216
ROE archetype: Low Return
DuPont ROE decomposition for HBMN.SW (annual period ending 2025-03-31)
ROE: 1.1198779339896925%
Net margin: 88.1064385839867%
Asset turnover: 0.011975959155899774
Equity multiplier (leverage): 1.0613356066698363
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for HBMN.SW (annual period ending 2026-03-31)
ROE: 16.2790645135362%
Net margin: 2446.32830232085%
Asset turnover: 0.006285462520943675
Equity multiplier (leverage): 1.0587110924049843
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for HBT (annual period ending 2022-12-31)
ROE: 15.110054813292223%
Net margin: 31.44445310846487%
Asset turnover: 0.041883167931576815
Equity multiplier (leverage): 11.473144698526893
Tax burden factor: 0.7409896311851949
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for HBT (annual period ending 2023-12-31)
ROE: 15.25660157010316%
Net margin: 29.170284782647222%
Asset turnover: 0.048230409200778125
Equity multiplier (leverage): 10.844166797972028
Tax burden factor: 0.7432970953138935
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for HBT (annual period ending 2024-12-31)
ROE: 13.882589805057727%
Net margin: 32.28025993299305%
Asset turnover: 0.04400621725236076
Equity multiplier (leverage): 9.772809425771758
Tax burden factor: 0.7370896357680499
ROE archetype: Standard Business
DuPont ROE decomposition for HBT (annual period ending 2025-12-31)
ROE: 13.276062556514379%
Net margin: 32.66663555881716%
Asset turnover: 0.04666116141536686
Equity multiplier (leverage): 8.709823179493545
Tax burden factor: 0.7368763515970375
ROE archetype: Standard Business
DuPont ROE decomposition for HCA (quarterly period ending 2025-03-31)
Net margin: 9.961246656841876%
Asset turnover: 0.3063814843305796
EBIT margin: 15.583210523443045%
Interest burden factor: 0.815061295971979
Tax burden factor: 0.7842715943274603
ROE archetype: Standard Business
DuPont ROE decomposition for HCA (quarterly period ending 2025-06-30)
Net margin: 10.163934426229508%
Asset turnover: 0.3118139004810029
EBIT margin: 15.947325987637731%
Interest burden factor: 0.813953488372093
Tax burden factor: 0.7830227743271222
ROE archetype: Standard Business
DuPont ROE decomposition for HCA (quarterly period ending 2025-09-30)
Net margin: 9.931631960753615%
Asset turnover: 0.32126958577500564
EBIT margin: 15.474140180575127%
Interest burden factor: 0.8155143338954469
Tax burden factor: 0.7870140612076096
ROE archetype: Standard Business
DuPont ROE decomposition for HCA (quarterly period ending 2025-12-31)
Net margin: 11.084917747142931%
Asset turnover: 0.32395593814073564
EBIT margin: 16.286578178650128%
Interest burden factor: 0.8407803650094399
Tax burden factor: 0.8095059880239521
ROE archetype: Standard Business
DuPont ROE decomposition for HCA (quarterly period ending 2026-03-31)
Net margin: 9.717933957820922%
Asset turnover: 0.31282638945731356
EBIT margin: 14.982468993667904%
Interest burden factor: 0.798812434509256
Tax burden factor: 0.8119807608220376
ROE archetype: Standard Business
DuPont ROE decomposition for HCAT (quarterly period ending 2025-03-31)
ROE: -6.300771474293479%
Net margin: -29.89686827093801%
Asset turnover: 0.08907376208860604
Equity multiplier (leverage): 2.3660190387223303
EBIT margin: -21.425963003538463%
ROE archetype: Low Return
DuPont ROE decomposition for HCAT (quarterly period ending 2025-06-30)
ROE: -11.314294865246191%
Net margin: -50.76498061223226%
Asset turnover: 0.10707676879424721
Equity multiplier (leverage): 2.081459720193606
EBIT margin: -10.313301371390345%
ROE archetype: Low Return
DuPont ROE decomposition for HCAT (quarterly period ending 2025-09-30)
ROE: -6.543040899524629%
Net margin: -29.124903371198723%
Asset turnover: 0.1268553022168888
Equity multiplier (leverage): 1.7709508881922675
EBIT margin: -22.940660089357074%
ROE archetype: Low Return
DuPont ROE decomposition for HCAT (quarterly period ending 2025-12-31)
ROE: -31.512732320933072%
Net margin: -121.88834879952866%
Asset turnover: 0.13705448208843876
Equity multiplier (leverage): 1.8863862572983003
EBIT margin: 4.366689430763668%
Interest burden factor: -27.796994786875192
ROE archetype: Low Return
DuPont ROE decomposition for HCAT (quarterly period ending 2026-03-31)
ROE: -57.83733802174904%
Net margin: -156.91390129458986%
Asset turnover: 0.15468412681929725
Equity multiplier (leverage): 2.3828742592954355
EBIT margin: -10.123523093447906%
ROE archetype: Low Return
DuPont ROE decomposition for HCG.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 3.3869802882226274
ROE archetype: Standard Business
DuPont ROE decomposition for HCG.NS (quarterly period ending 2025-03-31)
ROE: 0.7685540795475264%
Net margin: 1.2615052362751316%
Asset turnover: 0.17475834339557553
Equity multiplier (leverage): 3.4861611232221734
EBIT margin: 8.167218003873643%
Interest burden factor: 0.2858342077649528
Tax burden factor: 0.540381791483113
ROE archetype: Low Return
DuPont ROE decomposition for HCG.NS (quarterly period ending 2025-06-30)
Net margin: 0.9774436090225564%
EBIT margin: 8.152991173586141%
Interest burden factor: 0.23897353648757017
Tax burden factor: 0.5016778523489933
ROE archetype: Standard Business
DuPont ROE decomposition for HCG.NS (quarterly period ending 2025-09-30)
ROE: 2.0790564746608697%
Net margin: 3.202306404612809%
Asset turnover: 0.17993083444890673
Equity multiplier (leverage): 3.6082598719961356
EBIT margin: 9.379068758137517%
Interest burden factor: 0.32754916542720214
Tax burden factor: 1.0423814328960646
ROE archetype: Low Return
DuPont ROE decomposition for HCG.NS (quarterly period ending 2025-12-31)
Net margin: -1.2516239424569853%
EBIT margin: 7.756899775024557%
Interest burden factor: -0.12397875816993464
ROE archetype: Standard Business
DuPont ROE decomposition for HCG.NS (quarterly period ending 2026-03-31)
ROE: 0.2864821551400146%
Net margin: 0.621261283427394%
Asset turnover: 0.16578288557924203
Equity multiplier (leverage): 2.7815289921359234
EBIT margin: 9.575727752233618%
Interest burden factor: 0.02007387184840212
Tax burden factor: 3.232
ROE archetype: Low Return
DuPont ROE decomposition for HD (quarterly period ending 2025-01-31)
ROE: 45.1355421686747%
Net margin: 7.548357848075761%
Asset turnover: 0.41307129703804657
Equity multiplier (leverage): 14.475753012048193
EBIT margin: 11.321277453153336%
Interest burden factor: 0.8647385984427142
Tax burden factor: 0.7710316439413429
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for HD (quarterly period ending 2025-04-30)
ROE: 47.04350805070229%
Net margin: 8.61350863107186%
Asset turnover: 0.4082017247383191
Equity multiplier (leverage): 13.379650565262075
EBIT margin: 12.878863910076275%
Interest burden factor: 0.8848626534190532
Tax burden factor: 0.7558344341699692
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for HD (quarterly period ending 2025-07-31)
ROE: 48.88292158968851%
Net margin: 10.051461006692138%
Asset turnover: 0.45457466140578096
Equity multiplier (leverage): 10.698496240601504
EBIT margin: 14.477549307595469%
Interest burden factor: 0.916094584286804
Tax burden factor: 0.7578684429641965
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for HD (quarterly period ending 2025-10-31)
ROE: 31.614064351872173%
Net margin: 8.70816405494293%
Asset turnover: 0.40084721528864936
Equity multiplier (leverage): 9.056801720732189
EBIT margin: 12.94496034049139%
Interest burden factor: 0.8886605641696245
Tax burden factor: 0.7569896993903721
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for HD (quarterly period ending 2026-01-31)
ROE: 20.626579485739498%
Net margin: 6.73071888580554%
Asset turnover: 0.36143426897984093
Equity multiplier (leverage): 8.47883990533114
EBIT margin: 10.076443792868735%
Interest burden factor: 0.8568459340088335
Tax burden factor: 0.7795633717404488
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for HD (quarterly period ending 2026-04-30)
ROE: 24.64870536216135%
Net margin: 7.875014964683347%
Asset turnover: 0.3921614655467866
Equity multiplier (leverage): 7.981376700266047
EBIT margin: 11.926254040464505%
Interest burden factor: 0.8787392089941779
Tax burden factor: 0.7514279186657528
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for HDFCLIFE.NS (annual period ending 2023-03-31)
ROE: 10.530764330787635%
Net margin: 1.947827572462256%
Asset turnover: 0.2831721986780888
Equity multiplier (leverage): 19.092322938931478
Tax burden factor: 1.0671243609469154
ROE archetype: Standard Business
DuPont ROE decomposition for HDFCLIFE.NS (annual period ending 2024-03-31)
ROE: 11.2984533597074%
Net margin: 1.6426907576833898%
Asset turnover: 0.34552448848900735
Equity multiplier (leverage): 19.906016090668366
Tax burden factor: 1.0028095077309243
ROE archetype: Standard Business
DuPont ROE decomposition for HDFCLIFE.NS (annual period ending 2025-03-31)
ROE: 11.608157431932902%
Net margin: 2.010491344757153%
Asset turnover: 0.27297524601764755
Equity multiplier (leverage): 21.151336550345402
Tax burden factor: 0.9642587090109375
ROE archetype: Standard Business
DuPont ROE decomposition for HDFCLIFE.NS (annual period ending 2026-03-31)
ROE: 10.752474956634057%
Net margin: 2.0875438370887918%
Asset turnover: 0.2361162236320667
Equity multiplier (leverage): 21.81458758832633
Tax burden factor: 0.9745149898335143
ROE archetype: Standard Business
DuPont ROE decomposition for HDI.DE (quarterly period ending 2025-04-30)
ROE: 43.15524827152734%
Net margin: 8.61350863107186%
Asset turnover: 0.40194842522464375
Equity multiplier (leverage): 12.464739157762413
EBIT margin: 12.878863910076275%
Interest burden factor: 0.8848626534190532
Tax burden factor: 0.7558344341699692
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for HDI.DE (quarterly period ending 2025-07-31)
ROE: 48.88292158968851%
Net margin: 10.051461006692138%
Asset turnover: 0.45457466140578096
Equity multiplier (leverage): 10.698496240601504
EBIT margin: 14.477549307595469%
Interest burden factor: 0.916094584286804
Tax burden factor: 0.7578684429641965
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for HDI.DE (quarterly period ending 2025-10-31)
ROE: 31.614064351872173%
Net margin: 8.70816405494293%
Asset turnover: 0.40084721528864936
Equity multiplier (leverage): 9.056801720732189
EBIT margin: 12.94496034049139%
Interest burden factor: 0.8886605641696245
Tax burden factor: 0.7569896993903721
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for HDI.DE (quarterly period ending 2026-01-31)
ROE: 20.626579485739498%
Net margin: 6.73071888580554%
Asset turnover: 0.36143426897984093
Equity multiplier (leverage): 8.47883990533114
EBIT margin: 10.076443792868735%
Interest burden factor: 0.8568459340088335
Tax burden factor: 0.7795633717404488
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for HDI.DE (quarterly period ending 2026-04-30)
ROE: 24.64870536216135%
Net margin: 7.875014964683347%
Asset turnover: 0.3921614655467866
Equity multiplier (leverage): 7.981376700266047
EBIT margin: 11.926254040464505%
Interest burden factor: 0.8787392089941779
Tax burden factor: 0.7514279186657528
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for HEAD.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 2.082198952879581
ROE archetype: Standard Business
DuPont ROE decomposition for HEAD.L (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 2.386534149215157
ROE archetype: Standard Business
DuPont ROE decomposition for HEAD.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 2.9337404470375543
ROE archetype: Standard Business
DuPont ROE decomposition for HECPROJECT.NS (annual period ending 2022-03-31)
ROE: 1.7520082543595894%
Net margin: 1.1766777663934425%
Asset turnover: 0.5338914238757092
Equity multiplier (leverage): 2.7888532092909224
EBIT margin: 5.498252707845433%
Interest burden factor: 0.2320202986564619
Tax burden factor: 0.922373610613123
ROE archetype: Low Return
DuPont ROE decomposition for HECPROJECT.NS (annual period ending 2023-03-31)
ROE: 2.5454095863172874%
Net margin: 1.5237590825358227%
Asset turnover: 0.5964632599124812
Equity multiplier (leverage): 2.8006424698302386
EBIT margin: 5.976738656857496%
Interest burden factor: 0.3890685640362225
Tax burden factor: 0.6552784704904405
ROE archetype: Low Return
DuPont ROE decomposition for HECPROJECT.NS (annual period ending 2024-03-31)
ROE: 14.405609733356778%
Net margin: 6.391695295401107%
Asset turnover: 0.8937307944073147
Equity multiplier (leverage): 2.5217896596665637
EBIT margin: 7.428970246444276%
Interest burden factor: 1.207377138895983
Tax burden factor: 0.7125978303568731
ROE archetype: Standard Business
DuPont ROE decomposition for HECPROJECT.NS (annual period ending 2025-03-31)
ROE: 20.796181869339087%
Net margin: 8.245828913880665%
Asset turnover: 1.1976879153172746
Equity multiplier (leverage): 2.1057442310087033
EBIT margin: 12.317315660875066%
Interest burden factor: 0.8475115153973174
Tax burden factor: 0.7899009579477189
ROE archetype: Balanced Compounder
DuPont ROE decomposition for HECPROJECT.NS (annual period ending 2026-03-31)
ROE: 20.268034970656977%
Net margin: 7.140190071907308%
Asset turnover: 1.3974726086905302
Equity multiplier (leverage): 2.0312275011516085
EBIT margin: 11.336718962032649%
Interest burden factor: 0.8802846818570293
Tax burden factor: 0.715482881962187
ROE archetype: Balanced Compounder
DuPont ROE decomposition for HELI.V (quarterly period ending 2024-12-31)
ROE: -3.5701000388787416%
Net margin: -2853.426156141223%
Asset turnover: 0.0011054583034430822
Equity multiplier (leverage): 1.1318044097539415
EBIT margin: -2876.9368473396316%
ROE archetype: Low Return
DuPont ROE decomposition for HELI.V (quarterly period ending 2025-03-31)
ROE: -34.015412176703144%
Asset turnover: 0
Equity multiplier (leverage): 1.2627060222150026
ROE archetype: Low Return
DuPont ROE decomposition for HELI.V (quarterly period ending 2025-06-30)
ROE: -3.9409035693951147%
Asset turnover: 0
Equity multiplier (leverage): 1.4305317663657722
ROE archetype: Low Return
DuPont ROE decomposition for HELI.V (quarterly period ending 2025-09-30)
ROE: -3.717900935070431%
Asset turnover: 0
Equity multiplier (leverage): 1.3810559059822305
ROE archetype: Low Return
DuPont ROE decomposition for HELI.V (quarterly period ending 2025-12-31)
ROE: -3.8895852616144797%
Asset turnover: 0
Equity multiplier (leverage): 1.370950549075927
ROE archetype: Low Return
DuPont ROE decomposition for HELP (quarterly period ending 2024-12-31)
ROE: -3.1381118881118883%
Asset turnover: 0
Equity multiplier (leverage): 1.0553862803862804
ROE archetype: Low Return
DuPont ROE decomposition for HELP (quarterly period ending 2025-03-31)
ROE: -15.09190917907299%
Asset turnover: 0
Equity multiplier (leverage): 1.0696037133825393
ROE archetype: Low Return
DuPont ROE decomposition for HELP (quarterly period ending 2025-06-30)
ROE: -15.887860022697915%
Asset turnover: 0
Equity multiplier (leverage): 1.2366680660924076
ROE archetype: Low Return
DuPont ROE decomposition for HELP (quarterly period ending 2025-09-30)
ROE: -23.020671253413177%
Asset turnover: 0
Equity multiplier (leverage): 1.3487202560663836
ROE archetype: Low Return
DuPont ROE decomposition for HELP (quarterly period ending 2025-12-31)
ROE: -20.766551005774264%
Asset turnover: 0
Equity multiplier (leverage): 1.1407054199809739
ROE archetype: Low Return
DuPont ROE decomposition for HELP (quarterly period ending 2026-03-31)
ROE: -18.43946175960022%
Asset turnover: 0
Equity multiplier (leverage): 1.0702170450163342
ROE archetype: Low Return
DuPont ROE decomposition for HEMO.L (annual period ending 2022-12-31)
ROE: -122.68504587608524%
Asset turnover: 0
Equity multiplier (leverage): 2.1867011764996054
ROE archetype: Low Return
DuPont ROE decomposition for HEMO.L (annual period ending 2023-12-31)
ROE: -228.0312383827574%
Asset turnover: 0
Equity multiplier (leverage): 2.190904144773251
ROE archetype: Low Return
DuPont ROE decomposition for HEMO.L (annual period ending 2024-12-31)
ROE: -306.2472140587283%
Asset turnover: 0
Equity multiplier (leverage): 2.8325845160577385
ROE archetype: Low Return
DuPont ROE decomposition for HEMO.L (annual period ending 2025-12-31)
ROE: -1009.363592325493%
Asset turnover: 0
Equity multiplier (leverage): 4.173629503280037
ROE archetype: Low Return
DuPont ROE decomposition for HEN.DE (annual period ending 2022-12-31)
ROE: 6.245969142233467%
Net margin: 5.621288565432871%
Asset turnover: 0.6752185709978896
Equity multiplier (leverage): 1.6455821798878802
EBIT margin: 7.840335759253472%
Interest burden factor: 0.9618451025056948
Tax burden factor: 0.7454114860864416
ROE archetype: Standard Business
DuPont ROE decomposition for HEN.DE (annual period ending 2023-12-31)
ROE: 6.819641172960955%
Net margin: 6.2285023705494105%
Asset turnover: 0.6777609499771935
Equity multiplier (leverage): 1.6154791128186081
EBIT margin: 10.281677047503951%
Interest burden factor: 0.8535262206148282
Tax burden factor: 0.7097457627118644
ROE archetype: Standard Business
DuPont ROE decomposition for HEN.DE (annual period ending 2024-12-31)
ROE: 9.41737703803718%
Net margin: 9.413508755674975%
Asset turnover: 0.6248649107639104
Equity multiplier (leverage): 1.601003531516389
EBIT margin: 13.096451403687576%
Interest burden factor: 0.9632118853908737
Tax burden factor: 0.7462357693720162
ROE archetype: Standard Business
DuPont ROE decomposition for HEN.DE (annual period ending 2025-12-31)
ROE: 10.315385519050789%
Net margin: 10.0414735301293%
Asset turnover: 0.6430594086070707
Equity multiplier (leverage): 1.597485478586626
EBIT margin: 13.491095389119295%
Interest burden factor: 0.9869801084990959
Tax burden factor: 0.754122389153536
ROE archetype: Standard Business
DuPont ROE decomposition for HEPS (quarterly period ending 2025-03-31)
ROE: -13.897546154833101%
Net margin: -2.468102070823951%
Asset turnover: 0.7138695691095083
Equity multiplier (leverage): 7.887804524999476
EBIT margin: -2.7296505371718136%
ROE archetype: Low Return
DuPont ROE decomposition for HEPS (quarterly period ending 2025-06-30)
ROE: -22.7778173951944%
Net margin: -4.322938960405036%
Asset turnover: 0.5888065262616614
Equity multiplier (leverage): 8.948709060842477
EBIT margin: 0.20337712454380794%
Interest burden factor: -21.255777758200452
ROE archetype: Low Return
DuPont ROE decomposition for HEPS (quarterly period ending 2025-09-30)
ROE: -69.24861706593562%
Net margin: -6.650899143407118%
Asset turnover: 0.6303937696529646
Equity multiplier (leverage): 16.516530754590104
EBIT margin: -2.964610974943182%
ROE archetype: Low Return
DuPont ROE decomposition for HEPS (quarterly period ending 2025-12-31)
ROE: -219.93682826536295%
Net margin: -10.520561826235237%
Asset turnover: 0.8567544084576002
Equity multiplier (leverage): 24.400722002621425
EBIT margin: 0.9144559595227728%
Interest burden factor: -11.660250171226705
ROE archetype: Low Return
DuPont ROE decomposition for HEPS (quarterly period ending 2026-03-31)
ROE: -60.039068436452844%
Net margin: -4.287460501371789%
Asset turnover: 0.6550258270341793
Equity multiplier (leverage): 21.378409364271292
EBIT margin: -1.8998932555367019%
ROE archetype: Low Return
DuPont ROE decomposition for HERZ (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.0784106396283666
ROE archetype: Standard Business
DuPont ROE decomposition for HERZ (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.0423527731491684
ROE archetype: Standard Business
DuPont ROE decomposition for HERZ (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.0307701841532368
ROE archetype: Standard Business
DuPont ROE decomposition for HESTERBIO.NS (annual period ending 2023-03-31)
ROE: 9.715955168326715%
Net margin: 10.535869307868362%
Asset turnover: 0.39717090120991216
Equity multiplier (leverage): 2.321868956769458
EBIT margin: 15.620595961531958%
Interest burden factor: 0.9660531697341515
Tax burden factor: 0.6981869801265129
ROE archetype: Standard Business
DuPont ROE decomposition for HESTERBIO.NS (annual period ending 2024-03-31)
ROE: 7.103223357496685%
Net margin: 6.950017402953905%
Asset turnover: 0.4535849828287412
Equity multiplier (leverage): 2.253257946645204
EBIT margin: 13.882960209623505%
Interest burden factor: 0.7557473982970672
Tax burden factor: 0.6624104152974681
ROE archetype: Standard Business
DuPont ROE decomposition for HESTERBIO.NS (annual period ending 2025-03-31)
ROE: 9.04572319551189%
Net margin: 9.26577135473253%
Asset turnover: 0.4668366044040802
Equity multiplier (leverage): 2.0912059852705767
EBIT margin: 14.542818753977793%
Interest burden factor: 0.8746325398404172
Tax burden factor: 0.7284627631346188
ROE archetype: Standard Business
DuPont ROE decomposition for HESTERBIO.NS (annual period ending 2026-03-31)
ROE: 15.789566469821814%
Net margin: 17.28327505494605%
Asset turnover: 0.4755842985191069
Equity multiplier (leverage): 1.9209526341134513
EBIT margin: 23.188885113905936%
Interest burden factor: 0.983274122863885
Tax burden factor: 0.7580041141410413
ROE archetype: Balanced Compounder
DuPont ROE decomposition for HFG.DE (annual period ending 2022-12-31)
ROE: 13.23468111713214%
Net margin: 1.6694710274476812%
Asset turnover: 3.000631113916062
Equity multiplier (leverage): 2.6419341392246776
EBIT margin: 3.1614785992217898%
Interest burden factor: 0.8316008316008315
Tax burden factor: 0.635
ROE archetype: Standard Business
DuPont ROE decomposition for HFG.DE (annual period ending 2023-12-31)
ROE: 2.0023057919297282%
Net margin: 0.25537740568148914%
Asset turnover: 3.0334109159062397
Equity multiplier (leverage): 2.58473895141367
EBIT margin: 1.5967669746992077%
Interest burden factor: 0.6042868920032977
Tax burden factor: 0.2646657571623465
ROE archetype: Low Return
DuPont ROE decomposition for HFG.DE (annual period ending 2024-12-31)
ROE: -13.810327370907864%
Net margin: -1.7803766984715388%
Asset turnover: 2.84484839332948
Equity multiplier (leverage): 2.726672291596355
EBIT margin: -0.07309464451202799%
ROE archetype: Low Return
DuPont ROE decomposition for HFG.DE (annual period ending 2025-12-31)
ROE: -12.712758807092008%
Net margin: -1.3696603952195008%
Asset turnover: 3.0642905047081874
Equity multiplier (leverage): 3.028983963184253
EBIT margin: 1.5397586084487043%
Interest burden factor: -0.6042267050912584
ROE archetype: Low Return
DuPont ROE decomposition for HFG.L (annual period ending 2022-12-31)
ROE: 6.384184306802439%
Net margin: 0.5066015178292961%
Asset turnover: 2.9693174644578657
Equity multiplier (leverage): 4.244067641172945
EBIT margin: 1.6812298575735523%
Interest burden factor: 0.457804504769119
Tax burden factor: 0.6582022016613763
ROE archetype: Standard Business
DuPont ROE decomposition for HFG.L (annual period ending 2023-12-31)
ROE: 12.416212463519258%
Net margin: 0.9525003133224715%
Asset turnover: 3.1630835593447477
Equity multiplier (leverage): 4.121101807765499
EBIT margin: 2.143125704975561%
Interest burden factor: 0.5684210526315789
Tax burden factor: 0.7818930041152264
ROE archetype: Standard Business
DuPont ROE decomposition for HFG.L (annual period ending 2024-12-31)
ROE: 12.952044644827696%
Net margin: 1.0886062699534202%
Asset turnover: 3.00670479195425
Equity multiplier (leverage): 3.9570971403348367
EBIT margin: 2.4729156853509187%
Interest burden factor: 0.6074074074074074
Tax burden factor: 0.7247386759581882
ROE archetype: Standard Business
DuPont ROE decomposition for HFG.L (annual period ending 2025-12-31)
ROE: 24.051470146112678%
Net margin: 1.8981635267878327%
Asset turnover: 3.3742849479798402
Equity multiplier (leverage): 3.755141001743731
EBIT margin: 1.2883784938072416%
Interest burden factor: 1.0331491712707181
Tax burden factor: 1.4260249554367201
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for HFR.AX (annual period ending 2022-12-31)
ROE: -3.919067107423927%
Equity multiplier (leverage): 1.1378698100438598
ROE archetype: Low Return
DuPont ROE decomposition for HFR.AX (annual period ending 2023-12-31)
ROE: -8.510003349245393%
Equity multiplier (leverage): 1.2813907597902034
ROE archetype: Low Return
DuPont ROE decomposition for HFR.AX (annual period ending 2024-12-31)
ROE: -12.90311235405933%
Equity multiplier (leverage): 1.4711113626735488
ROE archetype: Low Return
DuPont ROE decomposition for HFR.AX (annual period ending 2025-12-31)
ROE: -63.305081501445294%
Equity multiplier (leverage): 1.6482752553727318
ROE archetype: Low Return
DuPont ROE decomposition for HG (annual period ending 2022-12-31)
ROE: -1.7986519273545307%
Net margin: -2.3375432798851805%
Asset turnover: 0.22007659437717875
Equity multiplier (leverage): 3.4963396066338923
ROE archetype: Low Return
DuPont ROE decomposition for HG (annual period ending 2023-12-31)
ROE: 15.100510871336656%
Net margin: 17.322046803214153%
Asset turnover: 0.25909568369745534
Equity multiplier (leverage): 3.364590811319713
Tax burden factor: 1.0982129213505158
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for HG (annual period ending 2024-12-31)
ROE: 28.018424335476443%
Net margin: 25.773488814329898%
Asset turnover: 0.32888120509382895
Equity multiplier (leverage): 3.30545647296439
Tax burden factor: 0.9864823991247827
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for HG (annual period ending 2025-12-31)
ROE: 32.61546836137002%
Net margin: 28.37286877291917%
Asset turnover: 0.34094165668738297
Equity multiplier (leverage): 3.371633054480706
Tax burden factor: 1.0183342324267644
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for HGEA.DE (annual period ending 2022-12-31)
ROE: -0.9541097055987294%
Net margin: -0.6214255102191615%
Asset turnover: 0.8619176511798237
Equity multiplier (leverage): 1.7813262238357255
EBIT margin: 0.14852143585499578%
Interest burden factor: -3.268656716417911
ROE archetype: Low Return
DuPont ROE decomposition for HGEA.DE (annual period ending 2023-12-31)
ROE: -17.44539551754851%
Net margin: -12.2640586797066%
Asset turnover: 0.7835835552436171
Equity multiplier (leverage): 1.8153538359699377
EBIT margin: -9.532785063347411%
ROE archetype: Low Return
DuPont ROE decomposition for HGEA.DE (annual period ending 2024-12-31)
ROE: -32.18553921320183%
Net margin: -22.11658012140715%
Asset turnover: 0.756969727327131
Equity multiplier (leverage): 1.922490953138779
EBIT margin: -16.39414487362999%
ROE archetype: Low Return
DuPont ROE decomposition for HGEA.DE (annual period ending 2025-12-31)
ROE: -78.23953551949356%
Net margin: -30.324548028751902%
Asset turnover: 1.0737515977358774
Equity multiplier (leverage): 2.4028579858344687
EBIT margin: -28.055979089522975%
ROE archetype: Low Return
DuPont ROE decomposition for HGS.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.4727875947918156
ROE archetype: Standard Business
DuPont ROE decomposition for HGS.NS (quarterly period ending 2024-12-31)
Net margin: -0.24810864151120718%
EBIT margin: -6.95268079507542%
Tax burden factor: -0.0639844886088221
ROE archetype: Standard Business
DuPont ROE decomposition for HGS.NS (quarterly period ending 2025-03-31)
ROE: 0.04850506375042172%
Net margin: 0.32814841610252704%
Asset turnover: 0.10392551405114912
Equity multiplier (leverage): 1.422311056226408
EBIT margin: 1.8577851273835977%
Interest burden factor: 4.796012980992119
Tax burden factor: 0.03682938617689705
ROE archetype: Low Return
DuPont ROE decomposition for HGS.NS (quarterly period ending 2025-06-30)
Net margin: 1.6502087613493273%
EBIT margin: -9.430711114056598%
ROE archetype: Standard Business
DuPont ROE decomposition for HGS.NS (quarterly period ending 2025-09-30)
ROE: -0.24115636514506428%
Net margin: -1.7900351957765066%
Asset turnover: 0.09636102529317939
Equity multiplier (leverage): 1.398091987632247
EBIT margin: -8.446069804956737%
ROE archetype: Low Return
DuPont ROE decomposition for HGS.NS (quarterly period ending 2025-12-31)
Net margin: 3.959383310706515%
EBIT margin: -9.891019322683231%
ROE archetype: Standard Business
DuPont ROE decomposition for HGS.NS (quarterly period ending 2026-03-31)
ROE: -0.0982681570868055%
Net margin: -0.7642877557229388%
Asset turnover: 0.09379996800318238
Equity multiplier (leverage): 1.3707341069925676
EBIT margin: -9.932975006223092%
Tax burden factor: -0.892357373519914
ROE archetype: Low Return
DuPont ROE decomposition for HHH.V (annual period ending 2022-12-31)
ROE: -93.97139890974147%
Asset turnover: 0
Equity multiplier (leverage): 3.2906002551342906
ROE archetype: Low Return
DuPont ROE decomposition for HHH.V (annual period ending 2023-12-31)
ROE: -68.61551378670603%
Asset turnover: 0
Equity multiplier (leverage): 2.1151508375904804
ROE archetype: Low Return
DuPont ROE decomposition for HHH.V (annual period ending 2024-12-31)
ROE: -78.05212602911178%
Asset turnover: 0
Equity multiplier (leverage): 1.8921817268606878
ROE archetype: Low Return
DuPont ROE decomposition for HHH.V (annual period ending 2025-12-31)
ROE: -240.3497996479154%
Asset turnover: 0
Equity multiplier (leverage): 2.1166344035358318
ROE archetype: Low Return
DuPont ROE decomposition for HIKAL.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 2.044457370782782
ROE archetype: Standard Business
DuPont ROE decomposition for HIKAL.NS (quarterly period ending 2025-03-31)
ROE: 3.976867622593678%
Net margin: 9.127272727272729%
Asset turnover: 0.21748586341887774
Equity multiplier (leverage): 2.0034064802344926
EBIT margin: 15.581818181818182%
Interest burden factor: 0.7969661610268378
Tax burden factor: 0.7349926793557834
ROE archetype: Low Return
DuPont ROE decomposition for HIKAL.NS (quarterly period ending 2025-06-30)
Net margin: -6.032857527605709%
EBIT margin: -3.851333153784002%
ROE archetype: Standard Business
DuPont ROE decomposition for HIKAL.NS (quarterly period ending 2025-09-30)
ROE: -2.922213849116637%
Net margin: -11.037318153067678%
Asset turnover: 0.1346047422417096
Equity multiplier (leverage): 1.9669262329397972
EBIT margin: -10.75268817204301%
ROE archetype: Low Return
DuPont ROE decomposition for HIKAL.NS (quarterly period ending 2025-12-31)
Net margin: -1.2023639698390056%
EBIT margin: 8.457305889545546%
Interest burden factor: -0.22168674698795185
ROE archetype: Standard Business
DuPont ROE decomposition for HIKAL.NS (quarterly period ending 2026-03-31)
ROE: 1.201201201201201%
Net margin: 2.785299806576402%
Asset turnover: 0.21856768411262367
Equity multiplier (leverage): 1.9731398064731398
EBIT margin: 12.263056092843327%
Interest burden factor: 0.1309148264984227
Tax burden factor: 1.7349397590361446
ROE archetype: Low Return
DuPont ROE decomposition for HIMX (quarterly period ending 2025-03-31)
ROE: 2.2029913177123475%
Net margin: 9.381173506621487%
Asset turnover: 0.13154119891408028
Equity multiplier (leverage): 1.7852285404281982
EBIT margin: 9.206397902692753%
Interest burden factor: 1.2129152781985257
Tax burden factor: 0.8401115597552347
ROE archetype: Low Return
DuPont ROE decomposition for HIMX (quarterly period ending 2025-06-30)
ROE: 2.0319717692924417%
Net margin: 7.919068147748116%
Asset turnover: 0.13674515158039374
Equity multiplier (leverage): 1.876426910062444
EBIT margin: 8.430711645359827%
Interest burden factor: 1.2183996907614998
Tax burden factor: 0.7709390862944163
ROE archetype: Low Return
DuPont ROE decomposition for HIMX (quarterly period ending 2025-09-30)
ROE: 0.15031666887944636%
Net margin: 0.6773414473717244%
Asset turnover: 0.11435657118590689
Equity multiplier (leverage): 1.940610452723751
EBIT margin: -0.3103017156973504%
Tax burden factor: 3.8764367816091956
ROE archetype: Low Return
DuPont ROE decomposition for HIMX (quarterly period ending 2025-12-31)
ROE: 0.7452016922938955%
Net margin: 3.31591827891334%
Asset turnover: 0.11694870589581143
Equity multiplier (leverage): 1.9216513406387365
EBIT margin: 3.362697642812474%
Interest burden factor: 1.2347342217015667
Tax burden factor: 0.7986242884250474
ROE archetype: Low Return
DuPont ROE decomposition for HIMX (quarterly period ending 2026-03-31)
ROE: 0.9132231575094303%
Net margin: 4.240426504801195%
Asset turnover: 0.11345161096475714
Equity multiplier (leverage): 1.898264422995776
EBIT margin: 5.105194133046585%
Interest burden factor: 1.0381889763779528
Tax burden factor: 0.800056882821388
ROE archetype: Low Return
DuPont ROE decomposition for HINDCOPPER.NS (annual period ending 2023-03-31)
ROE: 14.189944896066345%
Net margin: 17.743866354652003%
Asset turnover: 0.5577835717789823
Equity multiplier (leverage): 1.4337278856180349
EBIT margin: 21.493303187236307%
Interest burden factor: 1.1055596008411461
Tax burden factor: 0.7467288529174194
ROE archetype: Standard Business
DuPont ROE decomposition for HINDCOPPER.NS (annual period ending 2024-03-31)
ROE: 13.423040755516775%
Net margin: 17.324463897041667%
Asset turnover: 0.5409386562082591
Equity multiplier (leverage): 1.4323299947342805
EBIT margin: 23.114192222498016%
Interest burden factor: 1.0425130680094874
Tax burden factor: 0.7189514700673043
ROE archetype: Standard Business
DuPont ROE decomposition for HINDCOPPER.NS (annual period ending 2025-03-31)
ROE: 18.5864112696015%
Net margin: 22.45914937999768%
Asset turnover: 0.6042031442143017
Equity multiplier (leverage): 1.3696804534780807
EBIT margin: 27.140070305558776%
Interest burden factor: 1.125146781482404
Tax burden factor: 0.7354838709677418
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for HINDCOPPER.NS (annual period ending 2026-03-31)
ROE: 29.26456239013667%
Net margin: 29.842880906586267%
Asset turnover: 0.7436887909661284
Equity multiplier (leverage): 1.3185908346398463
EBIT margin: 40.98969433903415%
Interest burden factor: 0.9770851993056602
Tax burden factor: 0.745132714647284
ROE archetype: High-Margin Compounder